The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer
Keyword(s):
2016 ◽
Vol 119
(3)
◽
pp. 505-511
◽
2016 ◽
Vol 118
(2)
◽
pp. 369-374
◽
2016 ◽
Vol 96
(2)
◽
pp. S108-S109